Corcept Therapeutics | CORT - Capital Social e Reservas





Capital Social e Reservas Alterar Data
Acadia Pharmaceuticals USD 1.25B 20.68M 2026-03
Alaunos Therapeutics USD 1.29M 865K 2026-03
ANI Pharmaceuticals USD 562.3M 21.58M 2026-03
Ardelyx USD 148.62M 18.33M 2026-03
Aurora Cannabis CAD 511.83M 24.53M 2026-03
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Canopy Growth CAD 697.59M 60.58M 2026-03
Corcept Therapeutics USD 637.99M 9.82M 2026-03
Eli Lilly USD 31.2B 4.66B 2026-03
Esperion Therapeutics USD -307.93M 5.97M 2026-03
J&J USD 81.19B 358M 2026-03
Knight Therapeutics CAD 767.27M 480K 2025-12
Lexicon Pharmaceuticals USD 202.86M 95.32M 2026-03
Merck USD 45.88B 6.73B 2026-03
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Novartis USD 38.93B 7.2B 2026-03
Novartis USD 38.93B 7.2B 2026-03
Omeros USD -228.68M 15.13M 2025-06
Pacira USD 653.89M 39.22M 2026-03
Pfizer USD 90.1B 3.63B 2026-03
Supernus Pharmaceuticals USD 1.08B 15.09M 2026-03
TG Therapeutics USD 583.13M 64.89M 2026-03